Reports
Global Electrophysiology Devices Market Size, Share, Growth, Report: By Type: Treatment Devices, Diagnostic Devices; By Indication: Atrial Fibrillation (AF), Supraventricular Tachycardia (SVT), Atrioventricular Nodal Re-Entry Tachycardia (AVNRT), Others; By End User: Hospitals, Others; Regional Analysis; Supplier Landscape; 2023-2031
Global Electrophysiology Devices Market Outlook
The global Electrophysiology market value was USD 6.2 billion in 2022, driven by the increasing prevalence of cardiac arrhythmias across the globe. The market size is anticipated to grow at a CAGR of 10% during the forecast period of 2023-2031 to achieve a value of USD 14.55 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growth of the global electrophysiology devices market is fuelled by factors such as the emergence of technologically advanced electrophysiology products, the rapid growth in the ageing population with a high risk of target diseases, increased incidences of cases of arrhythmia across the globe, and the growing focus of key market players to broaden their geographic presence.
Market Segmentation
Electrophysiology is the branch of physiology, which is loosely related to the flow of ions (ion current) in biological tissues and, in general, to the electrical recording techniques which enable this flow to be measured.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The electrophysiology devices market can be segmented into type, indication, and end-use.
The industry can be broadly categorised on the basis of its type into:
- EP Ablation Catheters
- Cryoablation EP Catheters
- Radiofrequency Ablation Catheters
- Laser Ablation Systems
- Microwave Ablation Systems
- EP Diagnostic Catheters
- Conventional EP Diagnostic Catheters
- Advanced EP Diagnostic Catheters
- Ultrasound EP Diagnostic Catheters
- EP Laboratory Devices
- Access Devices
- Others
The industry can be divided based on indication as:
- Atrial Fibrillation (AF)
- Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
- Wolff-Parkinson-White Syndrome (WPW)
- Atrial Flutter
- Others
Based on its end-use segments, the industry can be categorised as:
- Hospitals
- Diagnostic Centres
- Clinics
- Others
The EMR report looks into the regional electrophysiology devices markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The increasing use of electrophysiological devices in the diagnosis and treatment of heart diseases such as atrial fibrillation, increased demand for cardiac rhythm management devices for continuous monitoring, and the increased use of these devices in out-of-hospital settings are some of the high-impact drivers for the electrophysiology devices market growth. The rising prevalence of heart failure and cardiac attack cases among millennials due to lifestyle habits such as smoking, and the high consumption of alcohol are the major driving factors for the electrophysiology devices market growth.
The lack of skilled and trained electrophysiologists in the developing countries and unfavourable healthcare reforms in the United States are hampering the development of the electrophysiology devices market. The main challenges faced by market players are the rising price pressure on players in the market and stringent regulations.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global electrophysiology devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott Laboratories
- Siemens Healthcare AG
- Nihon Kohden Corporation
- Boston Scientific Corporation
- General Electric Company
- Medtronic plc
- Koninklijke Philips N.V.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Electrophysiology Devices Market Overview
3.1 Global Electrophysiology Devices Market Historical Value (2016-2022)
3.2 Global Electrophysiology Devices Market Forecast Value (2023-2031)
4 Global Electrophysiology Devices Market Landscape
4.1 Global Electrophysiology Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Electrophysiology Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indication
4.2.3 Analysis by End User
5 Global Electrophysiology Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Electrophysiology Devices Market Segmentation
6.1 Global Electrophysiology Devices Market, by Type
6.1.1 Market Overview
6.1.2 Treatment Devices
6.1.2.1 Implantable Cardioverter Defibrillators (ICDs)
6.1.2.2 Automated external defibrillators (AEDs)
6.1.2.3 Pacemakers
6.1.2.3.1 CRT-P
6.1.2.3.2 CRT-D
6.1.2.3.3 Catheters
6.1.2.3.4 Others
6.1.3 Diagnostic Devices
6.1.3.1 Holter Monitoring Devices
6.1.3.2 Diagnostic Electrophysiology Catheters
6.1.3.3 Electrocardiograph (ECG)
6.1.3.4 EP Mapping & Imaging Systems
6.1.3.5 Insertable cardiac monitors (ICM)
6.1.3.6 Others
6.2 Global Electrophysiology Devices Market, by Indication
6.2.1 Market Overview
6.2.2 Atrial Fibrillation (AF)
6.2.3 Supraventricular Tachycardia (SVT)
6.2.4 Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
6.2.5 Wolff-Parkinson-White Syndrome (WPW)
6.2.6 Bradycardia
6.2.7 Others
6.3 Global Electrophysiology Devices Market, by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Ambulatory Surgical Centers
6.3.5 Others
6.4 Global Electrophysiology Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Electrophysiology Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Electrophysiology Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Electrophysiology Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Electrophysiology Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Electrophysiology Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Johnson & Johnson Private Limited
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BIOTRONIK SE & Co KG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Abbott
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 BD
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Baxter
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Koninklijke Philips N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 General Electric
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Medline Industries, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Danaher
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Siemens Healthcare GmbH
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 MicroPort Scientific Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 LivaNova PLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Cardiofocus
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Mogul Enterprises, Inc.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 AtriCure, Inc.
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Japan Lifeline Co., Ltd.
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 ARGON MEDICAL
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
18 Global Electrophysiology Devices Market-Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Pricing Models and Strategies (Additional Insight)
21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The Electrophysiology Devices Market was valued at USD 6.2 billion in 2022.
The market is expected to grow at a CAGR of 10% from 2023 to 2031 to reach a value of USD 14.55 billion by 2031.
The major drivers of the industry, such as the emergence of technologically advanced electrophysiology products, the rapid growth in the ageing population, increased incidences of cases of arrhythmia worldwide, and the growing focus of key market players, are expected to aid the market growth.
The key market trend guiding the industry growth includes the rising prevalence of heart failure and cardiac attack cases among millennials due to lifestyle habits such as smoking, leading to a heightened demand for electrophysiology devices.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading types of electrophysiology devices in the industry are EP ablation catheters, EP diagnostic catheters, EP laboratory devices, and access devices, among others.
The major indication sectors within the industry are atrial fibrillation (AF), atrioventricular nodal re-entry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and atrial flutter, among others.
The leading end use sectors within the industry are hospitals, diagnostic centres, and clinics, among others.
The major players in the industry are Abbott Laboratories, Siemens Healthcare AG, Nihon Kohden Corporation, Boston Scientific Corporation, General Electric Company, Medtronic plc, and Koninklijke Philips N.V., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$3499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER